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Abstract
Diarrhea is the second leading cause of death of children up to five years old in the develop-
ing countries. Among the etiological diarrheal agents are atypical enteropathogenic Escheri-
chia coli (aEPEC), one of the diarrheagenic E. coli pathotypes that affects children and
adults, even in developed countries. Currently, genotypic and biochemical approaches have
helped to demonstrate that some strains classified as aEPEC are actually E. albertii, a
recently recognized human enteropathogen. Studies on particular strains are necessary to
explore their virulence potential in order to further understand the underlying mechanisms of
E. albertii infections. Here we demonstrated for the first time that infection of fragments of
rat intestinal mucosa is a useful tool to study the initial steps of E. albertii colonization. We
also observed that an E. albertii strain can translocate from the intestinal lumen to Mesen-
teric Lymph Nodes and liver in a rat model. Based on our finding of bacterial translocation,
we investigated how E. albertii might cross the intestinal epithelium by performing infections
of M-like cells in vitro to identify the potential in vivo translocation route. Altogether, our
approaches allowed us to draft a general E. albertii infection route from the colonization till
the bacterial spreading in vivo.
Introduction
Escherichia albertii is a recently recognized close relative of Escherichia coli, which is an emerg-
ing human enteropathogen and avian pathogen [1,2]. Since it is difficult to discriminate from
other species of Enterobacteriaceae by common biochemical identification assays [3], E. albertii
isolates can be erroneously identified as Hafnia alvei, Shigella boydii, Yersinia ruckeri or E. coli
[4–6].
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Diarrheagenic E. coli (DEC) are classified into different categories according to their set of
virulence genes. Enteropathogenic E. coli (EPEC), one of the DEC categories, are sub-grouped
into typical (tEPEC) and atypical (aEPEC) based on the presence of the bfp operon (encoding
the bundle forming pilus—BFP) in tEPEC [7,8] and its absence in aEPEC ([9] and reviewed in
[10]).
Both EPEC groups use the type 3 secretion system (T3SS) to inject a number of effector pro-
teins directly into the host cell, including Tir (translocated intimin receptor), which is inserted
into the host cell membrane and acts as a receptor for the EPEC adhesin called intimin [11–
13]. Altogether, these events promote microvilli effacement and intimate bacterial adherence
to the enterocyte membrane leading to the so-called attaching and effacing (AE) lesion, in
which pedestal-like structures that are rich in actin and other cytoskeleton components are
formed [14–16]. The T3SS, Tir and Intimin-encoding genes are located in a pathogenicity
island named the locus of enterocyte-effacement (LEE). Besides the Tir-intimin interaction,
the presence of other potential adhesins such as E. coli common pilus (ECP) and type 1 pilus
(T1P) have been reported in aEPEC strains [17–19].
We have previously shown that certain aEPEC strains may invade cultured cells in vitro
[20–24] and that the aEPEC 1551–2 strain invades enterocytes through the basolateral surface
more effectively than through the apical surface [22]. Invasive enteropathogens can reach the
basolateral receptors and promote host cell invasion in vivo by transcytosis through M cells
[25]. M cells are recognized as part of the innate immune response (reviewed by [26,27]), and
are found on Peyer’s patches (gut associated lymphoid tissue—GALT) in association with
phagocytic cells, forming the follicle-associated epithelium (FAE) [26,27]. Hase et al., [28]
demonstrated that deficiency of bacterial FimH (the T1P adhesin) or its receptor, host glyco-
protein 2 (GP2), led to defects in bacterial transcytosis through M cells, resulting in an attenua-
tion of antigen-specific immune responses in Peyer’s patches.
There is little clinical evidence, but experimental data have indicated that, at least in the ini-
tial infection steps, M cells transport pathogens from the intestinal lumen to macrophages in
the lamina propria of the mucosa [29]. In fact, some enteropathogens such as Shigella, Salmo-
nella and Yersinia use M cells as the main entrance site in enterocytes [29,30]. After the trans-
location through M cells, Shigella is phagocytized, leading to the apoptosis of macrophages,
and is released to access the enterocyte basolateral surface [31].
During a recent evaluation of a collection of aEPEC strains in our laboratory, using a poly-
merase chain reaction system [32] and a preliminary analysis of the genomic sequence of the
LEE region of one strain (1551–2 strain), we have found out that six aEPEC strains, including
the 1551–2 strain, are actually E. albertii ([6] and unpublished data).
It is known that E. albertii strains share with EPEC and EHEC (Enterohemorrhagic E. coli)
the ability to promote AE lesions due to the presence of the LEE [4,6]. However, there is scarce
information regarding the virulence mechanisms that favor the interaction of E. albertii with
the intestinal mucosa [1].
Host colonization of the small and/or large intestines comprises the first step in the estab-
lishment of diarrheal diseases by bacterial pathogens, such as Vibrio cholera, EPEC and Salmo-
nella spp. [30]. However, studies on the interaction of E. albertii strains of human origin with
enterocytes are scarce and appropriate animal models to explore the interaction of E. albertii
strains with the intestinal mucosa have not been described [33,34]. To contribute to this issue,
we evaluated the rat intestinal mucosa as a model to study E. albertii adhesion, colonization
and translocation from the intestinal lumen to extra-intestinal sites. In addition, we investi-
gated the participation of the intimin-Tir interaction, the T3SS-translocon and T1P in this
infection model, as well as E. albertii translocation into M-like cells.
Rat intestinal colonization and translocation by E. albertii
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Materials and methods
Ethics statement
The protocols involving animal handling were approved by the Research Ethics Committee of
UNIFESP, project license number 0342/09. “Comitê de E´tica em Pesquisa da UNIFESP/ Hos-
pital São Paulo” (CEP UNIFESP/HU-HSP) is in accordance with Good Clinical Practice
(GCP) of the International Council for Harmonisation (ICH), formerly the International Con-
ference on Harmonisation (ICH). Animals are handled under "Brazilian Guidelines For The
Care And Use Of Animals In Educational Activities Or Scientific Research" standards that are
in accordance with Brazilian Law 11.794/2008, which defined procedures to be employed in
the scientific use of animals.
Bacterial strains
The invasive E. albertii 1551–2 strain (intimin subtype omicron) and its isogenic mutants
obtained in previous studies by our group (Table 1) were statically cultured in Luria Bertani
broth (LB) for 18 h at 37˚C. Antibiotics were added to select resistant strains as indicated in
Table 1. The mutant strain 1551–2Δtir was constructed employing the one-step allelic
exchange recombination method [35]. Primers containing a 40-bp region homologous to the
5’ and 3’ ends of the tir gene and a specific sequence for the zeocin (zeo) resistance-encoding
gene (tir-zeo-F ATG CCT 1 ATT GGT AAT CTT GGT CAT AAT CCC AAT GTG AGT GGT CAT
CGC TTG CAT TAG AAA GG and tir-zeo-R TTA AAC GAA ACG ATT GGA TCC CGG CAC TGG
TGG GTT ATT CGA ATG ATG CAG AGA TGT AAG) were used to amplify the Zeo cassette [36].
Amplicons obtained in the PCR reaction were electroporated into competent wild type bacte-
ria harboring the pKOBEG-Apra plasmid. The selection of recombinant bacteria were done
on Zeo-containing LB agar plates (60 μg/mL), and the tir deletion in the isogenic mutant was
confirmed by PCR. In addition, the loss of pKOBEG-Apra plasmid was confirmed by testing
the mutant strain for apramycin susceptibility.
Table 1. Bacterial strains.
Strain Characteristics Origin
E. albertii 1551–2 NalR Wild type strain (wt) [21]
E. albertii 1551-2eae::KnR eae mutant (eae) [21]
E. albertii 1551–2Δtir (ZeoR) tir mutant (Δtir) This
study
E. albertii 1551-2escN:KnR escN (T3SS) mutant (escN) [36]
E. albertii 1551-2escN::
KnR(pEscN)
escN mutant strain complemented with pACY184 carrying escN
gene of tEPEC E2348/69 (pEscN)
[36,37]
E. albertii 1551–2ΔfimA
(ZeoR)
fimA mutant (ΔfimA) [36]
E. albertii 1551–2ΔfimA
(pFimA) (ZeoRAmpR)
fimA mutant strain complemented with plasmid pBAD Myc
carrying fimA gene of aEPEC 1551–2 (pFimA)
[36]
tEPEC E2348/69 tEPEC prototype strain (E2348/69) [38]
R6 Rat E. coli strain that is able to translocate from lumen to extra-
intestinal organs (R6)
[39]
E. coli K12 HB101 Non-pathogenic laboratory strain (HB101) [40]
NalR: nalidixic acid resistant (20 μg/mL); KnR: kanamycin resistant (50 μg/mL); ZeoR: Zeocin resistant
(60 μg/mL); AmpR: ampicillin resistant (100 μg/mL).
doi:10.1371/journal.pone.0171385.t001
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Cell culture conditions
Caco-2 cells (ATCC HTB-37, purchased from Banco de Ce´lulas do Rio de Janeiro, Rio de
Janeiro, Brazil) and NIH 3T3 cells (ATCC CRL 2795, kindly provided by Dr. Beatriz Castilho,
UNIFESP) were grown in DMEM (Gibco Invitrogen, USA) supplemented with 10% fetal
bovine serum (Gibco Invitrogen, USA), 1% non-essential amino acids (Gibco Invitrogen,
USA) and 1% antibiotics (Pen Strep—Gibco Invitrogen, USA). Raji-B cells (ATCC CCL-86,
kindly provided by Dr. Roger Chammas, Universidade de São Paulo, São Paulo, Brazil) were
cultured in RPMI-1640 (Gibco Invitrogen, USA) supplemented with 10% fetal bovine serum,
200 mM glutamine (Gibco Invitrogen, USA) and 1% antibiotics. The cell lines were cultured at
37˚C in an atmosphere of 5% CO2.
Adhesion and Invasion assays
Quantitative assessment of bacterial association and invasion was performed as described pre-
viously [24,41]. Briefly, differentiated Caco-2 cells were infected with 107 colony-forming units
(CFU) of E. albertii strain 1551–2 and its isogenic mutants for 6 h. Thereafter, cell monolayers
were washed three times with phosphate buffered saline (PBS). While one set of monolayer-
containing wells was lysed in 1% Triton X-100 for 30 min at 37˚C, another set was treated with
100 μg/mL of gentamicin (Sigma, USA) for one hour at 37˚C, and then washed 5 times prior
to lysis. Following cell lysis, bacteria were resuspended in PBS and quantified by plating serial
dilutions onto MacConkey agar plates to obtain the total number of cell-associated bacteria
and of intracellular bacteria. The invasion indexes were calculated as the percentage of the
total number of cell-associated bacteria that were located in the intracellular compartment.
Assays were carried out in triplicate, and the results from at least three independent experi-
ments were expressed as the percentage of invasion (mean ± standard error).
Animals
Female Wistar-EPM rats, ~3 months-old and weighting 200–250 g, were obtained from the
Central Animal Facility of Universidade Federal de São Paulo (UNIFESP). After 14 days of
environment adaptation, stool samples were collected for coproculture and E. coli recovered
from each animal were screened for the presence of the eae gene, which encodes the adhesin
intimin, by PCR (AE11 5’-CCCGGCACAAGCATAAGCTAA-3’ and AE12 5’-ATGACT
CATGCCAGCCGCTCA-3’, generating a fragment of 917 bp [42]). This procedure was per-
formed to avoid the use of experimental animals that were colonized by either E. coli or Citro-
bacter rodentium, a murine pathogen that also promotes AE lesion formation [43]. Prior to the
assays, animals were fasted for 24 h with access to water.
In vivo organ culture (IVOC) bacterial colonization assay
For removal of ileum fragments, rats were held under anesthesia (pre-atropinization, induc-
tion of inhalation anesthesia with isoflurane and maintenance with intramuscular injection of
0.1 mL/100 g body weight ketamine + xylazine (4:1 1). After antisepsis, rats were subjected to
median laparotomy for the collection of intestinal fragments of ~ 0.5 cm2. Briefly, ileal seg-
ments were removed, sectioned longitudinally at its antimesenteric border and placed onto a
sterile filter paper with its serous portion facing the filter. This procedure allowed the exposure
of the entire apical surface of the mucosa to the bacterial inoculum. Fragments were kept in
Dulbecco’s Modified Eagle Medium (DMEM—Gibco Invitrogen, USA) supplemented with
10% fetal bovine serum (Gibco Invitrogen, USA) [44]. Fragments were infected with 1010 CFU
for 6 h of incubation (37˚C, 5% CO2); fragments were then washed, macerated and suspended
Rat intestinal colonization and translocation by E. albertii
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in PBS and plated in serial dilution onto MacConkey agar plates containing 20 μg/mL nalidixic
acid [21] for quantification (calculation of the total number of mucosa-associated bacteria).
Infected IVOC preparations were also fixed for electron microscopy analysis.
In vivo bacterial translocation assay
Animals were maintained under anesthesia (intramuscular injection of 0.1 mL/100 g body
weight of ketamine and xylazine (4:1) during the entire procedure. Additional half dose of anes-
thetic was administered when necessary. Bacterial translocation (BT) was induced by a midline
incision, oroduodenal cannulation, injection of 1010 CFU/mL resuspended in 10 mL of saline
through the catheter, and bacterial retention for a period of 2 h, within a portion between the
duodenum and ileum, by means of ligatures [39]. The E. coli rat strain R6, which is devoid of the
DEC virulence genes, such as the eae gene, was used as a BT-positive control strain [39], while
the non-pathogenic E. coli strain HB101 was used as BT-negative control. Bacterial inoculation
causes a transient dilation of the small bowel, which disappeared within a short period. Blood
(1 mL), mesenteric lymph nodes (MLN), spleen and liver were then collected, weighed, macer-
ated and suspended in PBS. Subsequently, bacterial colonies were enumerated after plating serial
dilutions onto MacConkey agar plates containing 20 μg/mL nalidixic acid, to estimate the num-
ber of translocated bacteria. The results were expressed by mean log10 values of CFU/g tissue.
M-like cell differentiation
M-like cells were obtained as previously described [45–47] with modifications. Briefly, Caco-2
cells (105 cells/filter) were seeded on the upper chamber of a Millicell filter (3.0-μm pore diam-
eter, Millipore, USA) and kept in DMEM as described above for 10 days at 37˚C in an atmo-
sphere of 5% CO2. The lower chamber was also filled with DMEM. During this incubation
period, transmembrane electric resistance (TEER) was measured every two days using the
Millicell1 ERS (Electrical Resistance System, Millipore), until it reached ~420 mΩ. After-
wards, Raji-B cells (106 cells/mL) were seeded at the Millicell lower chamber and cultured in
RPMI-1640, as described above, for 6 days. In parallel, in some filters, Caco-2 cells were kept
in monoculture for an additional 6 days (non-differentiated cells). Since galectin-9 is expressed
on M cells but not on Caco-2 cell surface [47], NIH 3T3 (positive control), Caco-2 (negative
control) and M-like cells were fixed and incubated with galectin-9 (M-20):sc-19294 (Santa
Cruz Biotechnology, INC), followed by Alexa Fluor 488 (donkey anti-goat IgG, Invitrogen)
incubation. Green fluorescent cells indicated the presence of galectin-9. Alternatively, donkey
anti-goat IgG-TR (Santa Cruz Biotechnology, INC), combined with phalloidin-FITC (Sigma,
USA) and DAPI (Molecular Probes, USA) were used.
In vitro bacterial translocation assay
Bacterial suspensions (107 CFU) in DMEM (as described above, except for 1% antibiotics)
were inoculated in the upper chamber of filters bearing either M-like/Caco-2 or Caco-2 cells
only for 6 h. Filters were transferred to a well containing fresh medium (DMEM without antibi-
otics) every hour and the medium from the lower chamber was collected for bacterial quantifi-
cation at 6 h [46]. In parallel, the transmembrane electric resistance (TEER) was measured. At
the end of the infection period, monolayers were washed with PBS and fixed for microscopy.
Scanning electron microscopy (SEM)
For SEM, preparations were fixed in 2% glutaraldehyde, post-fixed in 1% osmium tetroxide,
and dehydrated through a graded ethanol series (50, 70, 90, and 100%). After dehydration,
Rat intestinal colonization and translocation by E. albertii
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preparations were dried by the critical point method, mounted onto SEM stubs, coated with
gold and examined under SEM (QUANTA 250—FEI Company, Netherlands) at 12.5 kV [48].
Transmission electron microscopy (TEM)
Infected monolayers and ileum fragments were first fixed in 2% glutaraldehyde (EMS, USA)
for at least 24 h at 4˚C. After primary fixation, cells and fragments were washed 3 times with
PBS (10 min) and subjected to secondary fixation with 1% osmium tetroxide (EMS, USA) in
0.1 M sodium cacodylate buffer for 30 min. After being washed three times with distilled
water, preparations were dehydrated through a graded ethanol series (50%, 75%, 85%, 95%
and 100%), and propylene oxide (100%). Preparations were then gradually embedded in Ara-
ldite, which was allowed to polymerize for 24–48 h at 60˚C. Ultrathin sections were placed on
Formvar (EMS, USA) coated 200 mesh copper grids and stained with 4% aqueous uranyl ace-
tate (Merck, Germany) and Reynold’s lead citrate (Merck, Germany). Grids were examined
under TEM (LEO 906E– Zeiss, Germany) at 80 kV [48].
Statistical analysis
Differences in bacterial adherence, invasion percentages and translocation or differences in
TEER of infected M-like cells were assessed for significance by using an unpaired, two-tailed t
test (GraphPad Prism 4.0).
Results
Intimin, Tir and T3SS are essential for invasion of human intestinal cells
cultured in vitro
Strain 1551–2 had been previously evaluated regarding its ability to invade differentiated
Caco-2 cells [24]. In this study, Caco-2 cells were infected with bacterial suspensions of the
wild type or its isogenic mutant strains (Table 1). Compared to the wild type strain the adher-
ence index of mutant strains was not altered (Fig 1A) while the invasion index decreased sig-
nificantly (Fig 1B), except for fimA mutation that did not affect the adherence or invasion
indexes (Fig 1A–1B). These results confirm that E. albertii 1551–2 invasion depends on inti-
min and/or proteins injected by the T3SS, such as Tir, but not on T1P. Besides that, as the
T3SS mutant did not inject Tir into Caco-2 cells, it is possible that, in the absence of its recep-
tor, the 1551–2 intimin might recognize another host cell membrane structure as site for adhe-
sion, but not for invasion, as confirmed by results obtained in invasion assays with 1551–2Δtir
strain. Complementation of T3SS mutant restored the invasion index to the wild type values
(Fig 1B).
E. albertii 1551–2 colonizes rat enterocytes in in vitro organ culture
(IVOC)
To evaluate whether E. albertii 1551–2 could colonize the rat intestinal mucosa, ileal fragments
(approx. 0.5 cm2) were individually infected with bacterial suspensions of the wild type or its
isogenic mutant strains (Table 1). Methylene blue staining of the intestinal fragments was per-
formed to confirm that all tissue layers were well preserved (S1 Fig).
SEM images confirmed that the wild type strain strongly adhered to the intestinal mucosa
(Fig 2A), whereas the T3SS-mutant comparatively showed a weaker adherence (Fig 2B). Non-
infected fragments showed well-preserved bacterial-free brush borders (Fig 2C). Similarly to
the wild type strain, the intimin, Tir and T1P mutants remained adherent to the intestinal
mucosa (S2 Fig). Besides bacterial adherence, TEM images showed that the wild type strain
Rat intestinal colonization and translocation by E. albertii
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Fig 1. Quantitative assessment of association and invasion of E. albertii 1551–2 and its isogenic mutants to differentiated Caco-2
cells. Cells were infected with 107 CFU for 6 h, monolayers were washed and one set of monolayer was lysed while another set was submitted
to the gentamicin protection assay. The invasion indexes were calculated as the percentage of the total number of cell-associated bacteria that
were located in the intracellular compartment. Assays were carried out in triplicate, and the results from at least three independent experiments
were expressed as the percentage of invasion (mean ± standard error). A) Association. No statistical differences in the association of the wild
type, mutant and complemented mutant strains were found. B) Invasion: (**) indicates statistical differences between 1551–2 and the intimin
mutant (P = 0.0030). (***) indicates statistical differences between 1551–2 and Tir (P = 0.0002) or T3SS (P = 0.0004) mutants. (#) indicates
statistical differences between T3SS mutant and complemented T3SS (P = 0.0238) strains.
doi:10.1371/journal.pone.0171385.g001
Fig 2. IVOC and E. albertii colonization assays. Ileal fragments collected from 3 Wistar-EPM rats were inoculated with 1010 CFU of each
bacterial strain and incubated for 2 h at 37˚C. SEM: (A) wild type E. albertii strain 1551–2 (black arrow), (B) T3SS mutant (white arrow), (C)
non-infected control. TEM: (D) AE lesion underneath the wild type strain adherence site (#), (E) absence of AE lesion under the T3SS
mutant interaction and (F) Non-infected control. (#) indicates preserved brush borders. Bars, 2 μm. (G) Quantification assay. After the
incubation period, preparations were washed, macerated, and bacterial suspensions were diluted for seeding and CFU counting. (**)
Significantly less adherent than wild type (p = 0.013), (#) significantly more adherent than T3SS mutant (P = 0.02). eae, intimin mutant; Δtir,
Tir mutant; escN, T3SS mutant; pEscN, complemented T3SS mutant; ΔfimA, T1P mutant.
doi:10.1371/journal.pone.0171385.g002
Rat intestinal colonization and translocation by E. albertii
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caused AE lesions with characteristic pedestals underneath adhered bacteria on the rat muco-
sal surface (Fig 2D). In contrast, the T3SS-translocon mutant failed to cause AE lesions (Fig
2E), and non-infected fragments showed well-preserved bacterial-free brush borders (Fig 2F).
The number of CFU recovered from rat intestinal mucosa in vitro decreased significantly in
the absence of the T3SS-translocon, while mutant strains deficient in intimin, Tir or T1P pro-
duction, as well the T3SS mutant complemented strain, showed similar adherence levels in
comparison with the wild type strain (Fig 2G).
E. albertii strain translocates across rat intestinal barrier in vivo
To reduce the number of animals utilized in the next approach, we selected the T3SS-translo-
con mutant for in vivo comparison with wild type strain based on results obtained with the
IVOC infection assay. Our results demonstrated that E. albertii 1551–2 reached the liver, while
the T3SS-translocon mutant was not recovered from this organ. These findings suggest that, as
a consequence of the reduced adhesion of this mutant to the intestinal mucosa, as observed ex
vivo, fewer bacteria were available to cross the intestinal barrier, reach and survive in the MLN
(Fig 3).
E. albertii 1551–2 translocates across M-like cells
Considering our results in the BT assay described in Materials and Methods and that patho-
gens such as Shigella species use M cells to cross the intestinal barrier, we performed E. albertii
infection of M-like cells in vitro to identify the potential BT route employed in vivo. Prior to
infection, we confirmed the conversion of part of the Caco-2 cells to M-like cells as described
elsewhere [47], by demonstrating the expression of galectin-9 on M-like cell surface but not on
Caco-2 cells (S3 Fig). Moreover, cellular morphology alterations [45] were observed on M-like
cells, such as a reduced number of microvilli, flattened apical surface and disorganized
Fig 3. Bacterial translocation (BT) in vivo. E. albertii 1551–2 was recovered from the mesenteric lymph nodes (MLN) and liver. The T3SS
mutant strain was not recovered from any tested organs. E. coli R6 (BT-positive control) was recovered from all examined organs while E.
coli HB101 (BT-negative control) was not. escN, T3SS mutant.
doi:10.1371/journal.pone.0171385.g003
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cytoplasm (Fig 4A), while fully differentiated Caco-2 cells displayed preserved brush borders
(Fig 4B). The presence of M-like cells significantly increased bacterial translocation (Fig 4C) as
compared to differentiated Caco-2 cells (Fig 4D).
For quantitative E. albertii 1551–2 translocation assessment, tEPEC prototype strain
E2348/69 was used as control [46]. We demonstrated that E. albertii translocation through M-
like cells was significantly more effective than through differentiated Caco-2 cells (2,962.0
±546.0 and 184.2±91.6, p = 0.0024, respectively) (Fig 5A), and as previously demonstrated
[46], the presence of M-like cells did not increase the transcytosis of tEPEC E2348/69 in a sig-
nificant manner as compared to differentiated Caco-2 cells (1.203±0.528 and 0.417±0.247,
p = 0.1480, respectively). Additionally, E. albertii 1551–2 translocated through M-like cells
more effectively than tEPEC E2348/69 (p = 0.033, Fig 5A). In order to exclude bacterial para-
cellular migration due to increased permeability as an invasion route, transepithelial electrical
resistance was measured hourly during the infection period (S3 Fig). Comparison between M-
like cells infected with the wild type or the T3SS mutant strains demonstrated a significant
decrease in bacterial recovery (p = 0.0029, Fig 5B) with the latter strain, while complementa-
tion of the mutant strain restored its translocation capacity (p = 0.0418, Fig 5B and S4 Fig).
Contrarily, non-significant differences between CFU recovered from T1P mutant and its com-
plemented strains were observed with M-like cells (Fig 5B).
Discussion
Previous data from our laboratory showed that the 1551–2 strain invaded HeLa cells [21] with
invasion being dependent on the intimin-Tir interaction, since the intimin mutant (1551-
Fig 4. TEM of M-like and Caco-2 cells infected with E. albertii. M-like cells (A) showed few microvilli and a disorganized
morphology, while on apical surface of differentiated Caco-2 cells (B) microvilli were still present. After E. albertii infection, M-like cells
(C) allowed bacterial transcytosis (note bacteria crossing the filter membrane pore—white arrow), while in Caco-2 cells (D), E. albertii
remained on the cells surface (black arrow). Bars, 10 μm.
doi:10.1371/journal.pone.0171385.g004
Rat intestinal colonization and translocation by E. albertii
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2eae::Kn) was non-invasive [21]. Later on, we demonstrated that, in contrast with the wild
type 1551–2 strain that displayed a localized pattern of adherence (formation of compact bac-
terial clusters) in HeLa cells, its T3SS-mutant adhered weakly, while the intimin mutant
adhered, showing a T3SS-dependent diffuse pattern of adherence [36]. In addition, Pacheco
et al., 2014 [24] showed that the 1551–2 strain invades, persists and multiplies inside differenti-
ated Caco-2 cells up to 48 h.
In this work, we demonstrated for the first time that intimin, Tir and T3SS are essential for
invasion of enterocytes in vitro, since mutations in the corresponding genes abolished bacterial
uptake. Bacterial adherence was preserved in mutants, including the T3SS mutant, which did
not adhere on HeLa cells in a previous study [36]. This fact might be due to the interaction
between either intimin or T1P and Caco-2 cell surface receptors. It has been previously dem-
onstrated that Tir and Map, and EspF can induce tEPEC invasion of HeLa and Caco-2 cells,
respectively [49,50].
We have previously shown that an aEPEC strain, 1711–4, is able to translocate across the
rat gastrointestinal barrier and be isolated from the MLN, spleen and liver [51]. The mecha-
nisms promoting this bacterial translocation, however, are unknown. Generally, studies on
colonization and infection by enteropathogens are conducted with Caco-2 cells, but although
this cell line mimicries enterocytes from the human small intestine, it does not represent the
complex intestinal mucosa, since it is devoid of the mucosal layer and other intestinal cell
types. It was demonstrated that EHEC [52] as well as tEPEC E2348/69 [44] colonize human
IVOC. More recently, Etienne-Mesmin et al., [53] demonstrated that EHEC colonize and
translocate into ileum fragments from mice, where Peyer’s patches are available, but quantifi-
cation was not performed. In the present study, we evaluated E. albertii capacity to colonize
the rat intestinal mucosa in the IVOC model, to mimicry the first steps that lead to bacterial
translocation from the intestinal lumen to the extra-intestinal sites demonstrated in vivo. We
showed for the first time the interaction of E. albertii with rat intestinal mucosa ex vivo, which
Fig 5. Bacterial Translocation through the M-like cells. Caco-2 cells were cultured for 10 days on Millicell filter. One group was co-
cultured with Raji-B cell and control group were maintained in monoculture for 6 days. Then, upper chambers containing Caco-2 cells only or
M-like cells were infected with E. albertii 1551–2, isogenic mutants or complemented strains for 6 h, or with tEPEC E2348/69 for 3 h. Media
from the lower chamber were collected in three different periods during the incubation and seeded onto MacConkey agar for CFU counting.
(A) Translocation of E. albertii and tEPEC through the Caco-2 and M-like cells: (***) indicates statistical differences between the two
lineages infected with E. albertii strain (P<0.05). (##) indicates differences between M-like cells infected with 1551–2 and E2348/69 strains
(P<0.05). (B) Translocation of E. albertii, isogenic mutants and complemented strains: (**) indicates differences between M-like cells
infected with wt and T3SS mutant (P<0.05). (#) indicates difference between M-like cells infected with the T3SS mutant and its
complemented strain (P<0.05). No statistical differences were found between in the transcytosis of wt and T1P mutant or between T1P
mutant and its complement strains. eae, intimin mutant; tir, Tir mutant; escN, T3SS mutant; pEscN, complemented T3SS mutant; ΔfimA,
T1P mutant. pFimA, complemented T1P mutant.
doi:10.1371/journal.pone.0171385.g005
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could be an alternative model to study AE-producing pathogens’ interaction with more com-
plex intestinal tissues. In this model, colonization was detected after 30 min of infection, and
invasiveness was revealed after 2 h, when E. albertii 1551–2 could be found inside the entero-
cytes. Additionally, we demonstrated that E. albertii adherence to the rat IVOC depends on
T3SS, as previously demonstrated in human IVOC for tEPEC E2348/69 [44], but not on inti-
min, Tir or T1P, since in the absence of these genes, bacterial adherence was qualitatively and
quantitatively preserved. Thus, the use of this model may optimize the selection of potentially
invasive strains to be tested in vivo, thus reducing the number of animals used to assess the fate
of invasive E. albertii from the intestinal lumen to extra-intestinal sites.
We selected the T3SS mutant to compare to the wild type strain, since this mutant strain
had previously shown a significantly reduced capacity to interact with the host epithelium in
an ex vivo model, losing the capacity to invade cultured intestinal cells in vitro.
It has been reported that some E. albertii strains isolated from birds are able to adhere and
to invade HEp-2 cells [54] and to reach the liver and spleen of one day-old chicks in vivo, possi-
bly by disrupting the intestinal barrier, despite the minor intestinal mucosa alterations [54]. In
this study, using an in vivo bacterial translocation assay in rats, we recovered the E. albertii
1551–2 strain in the MLN and liver but not spleen, while the T3SS mutant completely lost
translocation capacity. It has been reported that T3SS-dependent effectors such as EspF, Map
and NleA disrupt tight junctions that contribute to the integrity of the intestinal barrier [55–
57]. In addition, some infectious processes can disturb the intestinal epithelium, for example,
neutrophil migration during inflammation; this event promotes a transitory epithelial barrier
destabilization, which exposes the basolateral side, either allowing enterocyte invasion [58] or
offering an alternative route for bacterial translocation from the intestinal lumen to extra-
intestinal niches.
Based on our finding that E. albertii 1551–2 can reach the MLN and liver in vivo and that
the invasion level through the basolateral surface is higher than at the apical surface of T84 cell
monolayers [22], we investigated how E. albertii might cross the intestinal epithelium. It is well
known that enteropathogens can reach basolateral receptors and promote enterocyte invasion
in vivo by transcytosis through M cells [25,59]. According to Hase and coworkers [28], bacte-
rial translocation depends on T1P-GP2 interaction, since isogenic mutant or non-T1P pro-
ducer strains were unable to translocate through M-like cells. On the other hand, Inman and
Cantey [60] described that a rabbit EPEC strain (RDEC-1) produced AE lesion on the M cell
membrane, suggesting that AE lesions could prevent bacterial internalization, thus preventing
transcytosis and antigen presentation, thereby delaying the immune response.
In this study, E. albertii 1551–2 translocation was significantly more effective through M-
like cells than Caco-2 cells only. This could not be observed with tEPEC as previously demon-
strated by [46]. We also demonstrated that translocation depended on functional T3SS, and
that T1P mutation did not compromise bacterial translocation, contrary to what was found by
Hase et al., [28]. These differences could be due to allelic FimH alterations in T1P in different
strains. Therefore, these data suggest that E. albertii 1551–2 may reach the enterocyte basolat-
eral surface in vivo after M cell translocation. Etienne-Mesmin et al., [53] also found that
EHEC O157:H7 and O113:H2 and their respective intimin and Shiga toxin mutants translo-
cated more effectively through M-like cells in comparison with Caco-2 cells. Cieza et al., [61]
reported that the translocation of adherent-invasive E. coli (AIEC) through M-like cells
depends on IbeA (an invasin); however, E. albertii strain 1551–2 is devoid of the ibeA gene
(not shown) and other invasion-related genes [62], reinforcing that the bacterial translocation
ability of this E. albertii strain is due to intimin-Tir interaction.
Altogether, our results demonstrated for the first time that both ex vivo and in vivo bacterial
infection of rat intestinal mucosa are useful models to study E. albertii interaction with the
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host. We also showed that E. albertii 1551–2 may also cross the intestinal mucosa in vivo possi-
bly using M cells as a route to reach extra-intestinal organs.
Supporting Information
S1 Fig. Light microscopy of rat intestinal mucosa prior to ex vivo infection. Ileal fragments
(approx. 0.5 cm2) were stained with Methylene blue to confirm, by the presence of neurons
from the myenteric plexus (Black arrows), that all tissue layers (as indicated) are well pre-
served. Magnification 400x.
(TIF)
S2 Fig. IVOC and E. albertii isogenic mutants colonization assays. Ileal fragments collected
from 3 Wistar-EPM rats were inoculated with 1010 CFU of each bacterial strain and incubated
for 2 h at 37˚C. SEM: (A) intimin mutant, (B) Tir mutant (white arrow), (C) Type 1 pilus
mutant. Bars: A and B = 5 μm; C = 200 mm.
(TIF)
S3 Fig. Caco-2 cells conversion into M-like cells and measurement of Transepithelial Elec-
trical Resistance during E. albertii infection. To verify the M-like cell conversion, immuno-
fluorescence staining was performed to detect Galectin-9 (green): A) NIH 3T3 cells (positive
control), B) Differentiated Caco-2 cells, C) M-like cells. D-E, a monolayer containing M-like
cells infected with E. albertii 1551–2 strain immunostained for Galectin-9 (red), combined
with phalloidin-FITC and DAPI, for actin (green) and nucleic acid (blue), respectively. D)
Merge image of actin and nucleic acid: insert (red square) indicates zoom of the white square
area, showing actin accumulation underneath bacterial adhesion sites, E) Merge image of
Galectin-9 and nucleic acid: insert (red square) indicates zoom of the white square area, show-
ing bacterial adhesion site (Original Magnification: A-C 1,000x and D-E 400x). F) Transe-
pithelial Electrical Resistance of monolayer containing M-like cells during infection with the
1551–2 strain. Non-significant differences were observed (p>0.05).
(TIF)
S4 Fig. TEM of M-like and Caco-2 cells infected with T3SS mutant and complemented E.
albertii strain 1551–2. After infection of M-like (A) and Caco-2 (B) cells with mutant strain,
none or rare bacteria were observed adhered to the host cell surface. Complemented strain
infecting M-like cells (C) presented intimate adherence and pedestal formation (AE lesion—
arrow), while the same strain infecting Caco-2 cells (D) loosely adhered to the tips of cells
microvilli. Bars, 1 μm.
(TIF)
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